DAWN logo

DAWN
Day One Biopharmaceuticals Inc

1,853
Mkt Cap
$2.22B
Volume
1.19M
52W High
$21.48
52W Low
$5.64
PE Ratio
-20.60
DAWN Fundamentals
Price
$21.47
Prev Close
$21.48
Open
$21.47
50D MA
$16.36
Beta
1.00
Avg. Volume
7.91M
EPS (Annual)
-$1.04
P/B
5.01
Rev/Employee
$888,662.92
$523.56
Loading...
Loading...
News
all
press releases
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - What's Next?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - What's Next...
MarketBeat·4d ago
News Placeholder
SG Americas Securities LLC Buys 323,747 Shares of Day One Biopharmaceuticals, Inc. $DAWN
SG Americas Securities LLC raised its stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 1,228.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 350,092 shares of the company's stock after purchasing an additional 323,747 shares during...
MarketBeat·8d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month High - Should You Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 52-Week High - Still a Buy...
MarketBeat·10d ago
News Placeholder
Hennion & Walsh Asset Management Inc. Buys 218,383 Shares of Day One Biopharmaceuticals, Inc. $DAWN
Hennion & Walsh Asset Management Inc. lifted its stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 229.7% in the 4th quarter, according to the company in its most...
MarketBeat·10d ago
News Placeholder
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 20.3% in March
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) saw a large decline in short interest in the month of March. As of March 13th, there was short interest totaling 8,091,418 shares, a...
MarketBeat·12d ago
News Placeholder
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders?
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 27, 2026 Insiders may stand to receive...
PR Newswire·15d ago
News Placeholder
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS...
Business Wire·15d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - Here's What Happened
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - Should You Buy...
MarketBeat·16d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year High - Should You Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 12-Month High - What's Next...
MarketBeat·21d ago
<
1
2
...
>

Latest DAWN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.